Search by Drug Name or NDC

    NDC 68180-0317-06 Imipramine Pamoate 150 mg/1 Details

    Imipramine Pamoate 150 mg/1

    Imipramine Pamoate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is IMIPRAMINE PAMOATE.

    Product Information

    NDC 68180-0317
    Product ID 68180-317_8f335412-54c9-428f-afac-c0bdae6384b8
    Associated GPIs 58200050200120
    GCN Sequence Number 046077
    GCN Sequence Number Description imipramine pamoate CAPSULE 150 MG ORAL
    HIC3 H2U
    HIC3 Description TRICYCLIC ANTIDEPRESSANTS,REL.NON-SEL.REUPT-INHIB
    GCN 16553
    HICL Sequence Number 001642
    HICL Sequence Number Description IMIPRAMINE PAMOATE
    Brand/Generic Generic
    Proprietary Name Imipramine Pamoate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Imipramine Pamoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name IMIPRAMINE PAMOATE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Tricyclic Antidepressant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090444
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0317-06 (68180031706)

    NDC Package Code 68180-317-06
    Billing NDC 68180031706
    Package 30 CAPSULE in 1 BOTTLE (68180-317-06)
    Marketing Start Date 2010-04-16
    NDC Exclude Flag N
    Pricing Information N/A